Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 10 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Curable inks comprising surfactant-coated magnetic nanoparticles
System and method for distributing emergency data messages to public safety answering points in a balanced manner
Fluid conduit with PTC fabric heating
System and method for infrared dongle
Light irradiation element, image forming structure, and image forming apparatus
Preparation and its use of derivatization reagent for detecting L-carnitine or D-carnitine
Selecting one of a plurality of print modes based on pixel coverage of a document
  Randomly Featured Patents
System for use in spinal stabilization
Outsourcing of email hosting services
Chemical analysis apparatus and method
Process and apparatus for producing sub-micron fibers, and nonwovens and articles containing same
Storm drain filter with variable flow capacity
Data mining of unfiltered controller data
Bicycle frame
Electronic device with biaxial pivoting mechanism
Using receive diversity to extend standby time in QPCH mode